NOV 22, 2016 6:27 PM PST

Scientists Discover "Quality Control" Department During T Cell Development

WRITTEN BY: Kara Marker
Thanks to immune soldiers called T cells, the body is protected from most infections: viral, bacterial, parasitical, or other. T cells endure a strenuous process to become the functional units that they are, and unfortunately sometimes errors are made during their “training” that causes them to detect healthy, host cells as “foreign,” causing autoimmune diseases that many people are familiar with: type 1 diabetes, rheumatoid arthritis, and others.
Walter and Eliza Hall Institute researcher Dr. Charis Teh has led a study revealing a quality control step in the development in immune T cells.
In a new study from the Walter and Eliza Hall Institute, scientists discovered a new, key player involved in T cell development in an organ called the thymus, essentially the “training ground” for developing T cells. The key player is a protein complex, specifically the “linear ubiquitin chain assembly complex” (LUBAC).

LUBAC’s newly discovered role in the Nature Communications study revolves around quality control: something every well-functioning business - or body system - needs to conduct successfully.
 
"Since the function of the thymus was discovered by Professor Jacques Miller almost 60 years ago, there has been an intense research effort to reveal the intricate details of how immune T cells develop," said one of the leading researchers, Dr. Charis Teh.

LUBAC regulates the quality of the immune respond by preventing autoimmune cells from continuing through the stages of development when they respond to “self,” also known as the host’s own healthy cells that don’t need immune cell mounting a response against them.

“We're excited by the prospect that this new checkpoint may be important for ensuring autoimmune T cells are not allowed to complete their development," Teh said.

Current treatments for autoimmune diseases suppress the entirety of the immune system, making people more vulnerable to infection from any bacteria and viruses that they encounter. With this new finding, though, the potential for a more targeted treatment grows, by only targeted T cells with dysfunctional LUBAC.

New applications in the future involve new treatments for autoimmune diseases and diseases caused by mutations in the gene coding for LUBAC, which past research has connected to rare immune diseases.
 


Source: Walter and Eliza Hall Institute
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 04, 2020
Microbiology
Why the Brain Parasite You May Carry Isn't a Problem
AUG 04, 2020
Why the Brain Parasite You May Carry Isn't a Problem
Toxoplasma gondii is a parasite transmitted by cats and contaminated meat, and it's thought that over 30 million America ...
AUG 17, 2020
Immunology
Nervous Protein Neuromedin B May Prevent Immune Reactivity
AUG 17, 2020
Nervous Protein Neuromedin B May Prevent Immune Reactivity
A protein produced by the nervous system seems to play a role in regulating the immune system. For people with inflammat ...
AUG 24, 2020
Immunology
Injectable Drug Stops HIV From Entering Cells
AUG 24, 2020
Injectable Drug Stops HIV From Entering Cells
Once in the body, HIV tracks down T cells that bear the CD4 receptor. It attaches to these immune cells, fusing itself w ...
OCT 01, 2020
Drug Discovery & Development
HPV Vaccine Protects Against Cervical Cancer, Large Study Finds
OCT 01, 2020
HPV Vaccine Protects Against Cervical Cancer, Large Study Finds
It has been known for some time that the HPV vaccine protects against human papillomavirus infection, genital warts, and ...
OCT 05, 2020
Immunology
Can't Shed Those Extra Pounds? An Inflammatory Gene Could Be to Blame.
OCT 05, 2020
Can't Shed Those Extra Pounds? An Inflammatory Gene Could Be to Blame.
  Australian scientists have zeroed in on a gene linked to an increased obesity risk: a regulator of inflammation c ...
OCT 21, 2020
Drug Discovery & Development
Experimental Vaccine Shows Promise in Halting Alzheimer's
OCT 21, 2020
Experimental Vaccine Shows Promise in Halting Alzheimer's
In a preclinical study, researchers from the Univerity of South Florida have found that a vaccine that targets neurotoxi ...
Loading Comments...